Quest Diagnostics | DGX - Sales Revenues



Quest Diagnostics reported $2.49B in Sales Revenues for its fiscal quarter ending in September of 2024.

Sales Change Date
Acadia Healthcare USD 815.6M 19.6M Sep/2024
Agilent USD 1.7B 120M Oct/2024
Amedisys USD 587.7M 3.49M Sep/2024
Baxter International USD 3.85B 40M Sep/2024
Bruker USD 864.4M 63.7M Sep/2024
Cardinal Health USD 52.3B 7.6B Sep/2024
Catalent USD 1.02B 280M Sep/2024
Centene USD 42.02B 2.18B Sep/2024
Charles River Laboratories USD 1.01B 20M Sep/2024
Cigna USD 63.7B 3.18B Sep/2024
CVS Health USD 95.4B 4.2B Sep/2024
Danaher USD 5.8B 100M Sep/2024
DaVita Healthcare Partners USD 3.26B 70M Sep/2024
Elevance Health 44.7B 1.48B Sep/2024
Encompass Health USD 1.35B 50M Sep/2024
HCA USD 17.49B 0 Sep/2024
Henry Schein USD 3.17B 30M Sep/2024
Humana USD 29.4B 140M Sep/2024
Illumina USD 1.08B 30M Sep/2024
IQVIA Holdings USD 3.9B 90M Sep/2024
Laboratory Of America USD 3.28B 60M Sep/2024
McKesson USD 93.65B 14.37B Sep/2024
Mettler Toledo International USD 954.54M 7.79M Sep/2024
Molina Healthcare USD 10.34B 460M Sep/2024
Owens Minor USD 2.72B 50M Sep/2024
Patterson Companies USD 1.54B 1.74M Jul/2024
Quest Diagnostics USD 2.49B 90M Sep/2024
Revvity USD 684M 8M Sep/2024
Tenet Healthcare USD 5.12B 20M Sep/2024
Thermo Fisher Scientific USD 10.6B 60M Sep/2024
UnitedHealth 100.82B 1.92B Sep/2024
Universal Health Services USD 3.96B 50M Sep/2024
Walgreens Boots Alliance USD 37.55B 1.15B Aug/2024
Waters USD 740M 31M Sep/2024
Zoetis USD 2.4B 40M Sep/2024